Use of Gadolinium in Individuals with Reduced Kidney Function.
作者信息
Kalantari Kambiz, Swaminathan Sundararaman
机构信息
Division of Nephrology, University of Virginia Health System, Charlottesville, Virginia.
Division of Nephrology, Mayo Clinic Arizona, Phoenix, Arizona.
出版信息
Clin J Am Soc Nephrol. 2021 Feb 8;16(2):304-306. doi: 10.2215/CJN.13950820. Epub 2021 Jan 11.
Abstract
摘要
相似文献
1
Use of Gadolinium in Individuals with Reduced Kidney Function.钆在肾功能减退个体中的应用。
Clin J Am Soc Nephrol. 2021 Feb 8;16(2):304-306. doi: 10.2215/CJN.13950820. Epub 2021 Jan 11.
2
Gadolinium in pediatric cardiovascular magnetic resonance: what we know and how we practice.钆在儿科心血管磁共振成像中的应用：我们的所知与所为。
J Cardiovasc Magn Reson. 2012 Aug 7;14(1):56. doi: 10.1186/1532-429X-14-56.
3
Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging.患有慢性肾脏病且接受钆增强磁共振成像检查的非透析患者发生肾源性系统性纤维化的风险较低。
Clin J Am Soc Nephrol. 2010 Mar;5(3):484-9. doi: 10.2215/CJN.06580909. Epub 2010 Jan 21.
4
Gadolinium-Induced Fibrosis.钆诱导纤维化。
Annu Rev Med. 2016;67:273-91. doi: 10.1146/annurev-med-063014-124936.
5
Gadolinium-induced NSF claim resolved in favor of plaintiff.钆诱导的 NSF 索赔案以原告胜诉告终。
J Med Assoc Ga. 2012;101(3):32-3.
6
Prospective Cohort Study of Nephrogenic Systemic Fibrosis in Patients With Stage 3-5 Chronic Kidney Disease Undergoing MRI With Injected Gadobenate Dimeglumine or Gadoteridol.对接受注射钆贝葡胺或钆特醇磁共振成像检查的3 - 5期慢性肾脏病患者进行的肾源性系统性纤维化前瞻性队列研究。
AJR Am J Roentgenol. 2015 Sep;205(3):469-78. doi: 10.2214/AJR.14.14268.
7
Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis.接受 II 类钆基造影剂的 4 或 5 期慢性肾脏病患者发生肾源性系统纤维化的风险：系统评价和荟萃分析。
JAMA Intern Med. 2020 Feb 1;180(2):223-230. doi: 10.1001/jamainternmed.2019.5284.
8
Nephrogenic systemic fibrosis.肾源性系统性纤维化
Magn Reson Imaging Clin N Am. 2009 Feb;17(1):159-67. doi: 10.1016/j.mric.2009.01.003.
9
Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.肾源性系统性纤维化：钆造影剂更换和采用钆造影剂政策后发病率的变化——来自两所美国大学的报告。
Radiology. 2009 Dec;253(3):689-96. doi: 10.1148/radiol.2533090649. Epub 2009 Sep 29.
10
Prophylactic Hemodialysis for Protection Against Gadolinium-Induced Nephrogenic Systemic Fibrosis: A Doll's House.预防钆诱导的肾源性系统性纤维化的预防性血液透析：一个玩偶之家。
Adv Chronic Kidney Dis. 2017 May;24(3):133-135. doi: 10.1053/j.ackd.2017.03.007.
Zotero 插件